APONTIS PHARM. AG INH ON/ DE000A3CMGM5 /
| 2024-05-10 5:36:07 PM | Chg. +0.040 | Volume | Bid2024-05-10 | Ask2024-05-10 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 8.760EUR | +0.46% | 1,497 Turnover: 13,151.820 |
-Bid Size: - | -Ask Size: - | 74.46 mill.EUR | 0.00% | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.09 EUR | - |
| EPS Diluted: | -0.09 EUR | - |
| Revenues per Share: | 6.02 EUR | - |
| Book Value per Share: | 4.79 EUR | - |
| Cash Flow per Share: | 0.40 EUR | - |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 51.20 EUR | - |
| Net Income: | 1.00 EUR | - |
| Operating Cash Flow: | 3.40 EUR | - |
| Cash and Cash Equivalents: | 29.80 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 1.45 | 3.32 |
| P/BV ratio: | 1.83 | 4.18 |
| P/CF Ratio: | 21.90 | 50.00 |
| PEG: | - | - |
| Earnings Yield: | -1.00% | -0.44% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 74.46 mill. EUR | 170 mill. EUR |
| Free Float Market Cap.: | 46.34 mill. EUR | 105.81 mill. EUR |
| Market Cap. / Employee: | 423,068.1818 EUR | 965,909.0909 EUR |
| Shares Outstanding: | 8.5 mill. | |
Profitability
| Gross Profit Margin: | 27.54% |
| EBIT Margin: | 20.31% |
| Net Profit Margin: | 1.95% |
| Return on Equity: | 2.46% |
| Return on Assets: | 1.85% |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | 32.92% |
| Dynam. Debt / Equity Ratio: | 394.12% |
Efficiency
| Employees: | 176 |
| Personal Expenses / Employee: | 111,931.82 EUR |
| Revenues / Employee: | 290,909.09 EUR |
| Net Income / Employee: | 5,681.82 EUR |
| Total Assets / Employee: | 307,386.36 EUR |
| * Fiscal Year End: | 2021-12-31 |
| Accounting Standard: | HGB |
| Currency: | EUR |
